| Alkem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539523 |
NSE Symbol : ALKEM |
P/E(TTM) : 32.28 |
|
ISIN Demat : INE540L01014 |
Div & Yield% : 0.70 |
EPS(TTM) : 176.61 |
|
Book Value(₹) : 882.75 |
Market Cap(₹Cr) : 68,168.19 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,500.10 | 2,365.37 | 2,494.59 | 2,634.59 | 2,253.17 | 2,237.99 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,500.10 | 2,365.37 | 2,494.59 | 2,634.59 | 2,253.17 | 2,237.99 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 106.10 | 83.79 | 95.66 | 61.84 | 64.70 | 76.60 |
| Total Income | 2,606.20 | 2,449.16 | 2,590.25 | 2,696.43 | 2,317.87 | 2,314.59 |
| Total Expenditure | 1,879.47 | 1,970.37 | 1,976.64 | 1,979.99 | 1,919.42 | 1,906.00 |
| PBIDT | 726.73 | 478.79 | 613.61 | 716.44 | 398.45 | 408.59 |
| Interest | 21.44 | 20.68 | 21.11 | 18.70 | 21.42 | 21.74 |
| PBDT | 705.29 | 458.11 | 592.50 | 697.74 | 377.03 | 386.85 |
| Depreciation | 64.35 | 69.10 | 58.12 | 59.02 | 58.11 | 57.16 |
| Tax | 111.26 | 77.41 | 90.46 | 111.48 | 53.93 | 53.63 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -53.57 | -13.37 | -60.31 | -119.27 | -6.45 | 21.27 |
| Reported Profit After Tax | 583.25 | 324.97 | 504.23 | 646.51 | 271.44 | 254.79 |
| Extra-ordinary Items | 0.00 | -10.03 | -42.62 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 583.25 | 335.00 | 546.85 | 646.51 | 271.44 | 254.79 |
| EPS (Unit Curr.) | 48.78 | 27.18 | 42.17 | 54.07 | 22.70 | 21.31 |
| EPS (Adj) (Unit Curr.) | 48.78 | 27.18 | 42.17 | 54.07 | 22.70 | 21.31 |
| Calculated EPS (Unit Curr.) | 48.79 | 27.18 | 42.18 | 54.08 | 22.71 | 21.31 |
| Calculated EPS (Adj) (Unit Curr.) | 48.79 | 27.18 | 42.18 | 54.08 | 22.71 | 21.31 |
| Calculated EPS (Ann.) (Unit Curr.) | 195.15 | 108.73 | 168.71 | 216.31 | 90.82 | 85.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 195.15 | 108.73 | 168.71 | 216.31 | 90.82 | 85.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 1,750.00 | 0.00 | 0.00 | 0.00 |
| Equity | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.07 | 20.24 | 24.60 | 27.19 | 17.68 | 18.26 |
| PBDTM(%) | 28.21 | 19.37 | 23.75 | 26.48 | 16.73 | 17.29 |
| PATM(%) | 23.33 | 13.74 | 20.21 | 24.54 | 12.05 | 11.38 |